- Credit Type: CNE
- Credit Amount: 1.50
- Cost: $10.00
- Release: Sep 1, 2021
- Expires: Sep 1, 2024
- Estimated Time to Complete:
1 Hour(s) , 30 Minutes -
Average User Rating:
( Ratings)
Faculty
Hannah Johnson, PharmD, BCPS, BCPPAssociate Professor
University of Kentucky College of Pharmacy
Lexington, Kentucky
Target Audience
The target audience for this activity are nursing professionals, including, but not limited to advanced practice registered nurses.Objectives
Upon completion of this educational activity, you should be able to:- Review FDA-approved medications for opioid use disorder (MOUD)
- Describe the pharmacology of buprenorphine for medicationassisted treatment for opioid use disorder (OUD)
- Discuss practice considerations for buprenorphine treatment for OUD
Accreditation
In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CNEThe University of Kentucky, College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
This educational activity is offered for a maximum of 1.50 ANCC contact hours.
The Kentucky Board of Nursing (KBN) approves The University of Kentucky, College of Nursing (UKCON) as a provider as well. ANCC and KBN approval of a continuing nursing education provider does not constitute endorsement of program content nor commercial sponsors. The University of Kentucky does not approve commercial products. This educational activity is offered for a maximum of 1.8 KBN contact hours.
Provider #: 3-0008-12-21-0250. In order to receive credit, participants complete this CNE activity and submit a credit application and evaluation form online. Certificates may be printed once the evaluation is completed.